tetano
Editor, Senior Moderator
Euro Surveill. 2020 Feb;25(8). doi: 10.2807/1560-7917.ES.2020.25.8.2000170. [h=1]Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.[/h]
Bordi L[SUP]1[/SUP], Nicastri E[SUP]1[/SUP], Scorzolini L[SUP]1[/SUP], Di Caro A[SUP]1[/SUP], Capobianchi MR[SUP]1[/SUP], Castilletti C[SUP]1[/SUP], Lalle E[SUP]1[/SUP], On Behalf Of Inmi Covid-Study Group And Collaborating Centers[SUP]2,[/SUP][SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.
[h=4]KEYWORDS:[/h] SARS-CoV-2; differential diagnosis; rapid molecular assay; respiratory pathogens
PMID: 32127123 DOI: 10.2807/1560-7917.ES.2020.25.8.2000170
Free full text
Bordi L[SUP]1[/SUP], Nicastri E[SUP]1[/SUP], Scorzolini L[SUP]1[/SUP], Di Caro A[SUP]1[/SUP], Capobianchi MR[SUP]1[/SUP], Castilletti C[SUP]1[/SUP], Lalle E[SUP]1[/SUP], On Behalf Of Inmi Covid-Study Group And Collaborating Centers[SUP]2,[/SUP][SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.
[h=4]KEYWORDS:[/h] SARS-CoV-2; differential diagnosis; rapid molecular assay; respiratory pathogens
PMID: 32127123 DOI: 10.2807/1560-7917.ES.2020.25.8.2000170
Free full text